Literature DB >> 19671029

Influence of obesity on breast cancer receptor status and prognosis.

David P Rose1, Linda Vona-Davis.   

Abstract

Pre-existing obesity and postoperative weight gain are related to a poor prognosis in breast cancer regardless of menopausal status. Delayed diagnosis may be one cause, but of more biological significance, especially in younger women, is the association of adiposity with estrogen receptor-negative tumors with a propensity for distant metastasis. After the menopause, the major mechanism for the relationship is the elevated estrogen synthesis by adipose tissue; these hormone-dependent tumors are estrogen receptor-positive. Insulin and some adipokines also stimulate breast cancer growth and metastasis, both directly and most probably by enhanced angiogenesis. Weight control is important, not only to target breast cancer progression, but also to reduce the risk of nonbreast cancer mortality risk associated with excess adiposity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671029     DOI: 10.1586/era.09.71

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  30 in total

1.  Exercise and dietary advice intervention for survivors of triple-negative breast cancer: effects on body fat, physical function, quality of life, and adipokine profile.

Authors:  Anne K Swisher; Jame Abraham; Daniel Bonner; Diana Gilleland; Gerald Hobbs; Sobha Kurian; Mary Anne Yanosik; Linda Vona-Davis
Journal:  Support Care Cancer       Date:  2015-03-01       Impact factor: 3.603

2.  Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.

Authors:  Jeong Won Park; Li Zhao; Mark C Willingham; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 3.  The obesity-inflammation-eicosanoid axis in breast cancer.

Authors:  Linda Vona-Davis; David P Rose
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-30       Impact factor: 2.673

4.  Estrogen Protects against Obesity-Induced Mammary Gland Inflammation in Mice.

Authors:  Priya Bhardwaj; Baoheng Du; Xi Kathy Zhou; Erika Sue; Dilip Giri; Michael D Harbus; Domenick J Falcone; Clifford A Hudis; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-02

5.  Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.

Authors:  Henry M Kuerer; Sara A Lari; Banu K Arun; Chung-Yuan Hu; Abenaa Brewster; Elizabeth A Mittendorf; Constance T Albarracin; Gildy V Babiera; Abigail S Caudle; Jamie L Wagner; Jennifer K Litton; Isabelle Bedrosian; Funda Meric-Bernstam; Anthony Lucci; Kelly K Hunt
Journal:  Breast Cancer Res Treat       Date:  2012-03-04       Impact factor: 4.872

6.  Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer.

Authors:  Patrick G Morris; Clifford A Hudis; Dilip Giri; Monica Morrow; Domenick J Falcone; Xi Kathy Zhou; Baoheng Du; Edi Brogi; Carolyn B Crawford; Levy Kopelovich; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-27

7.  Early developments in gene-expression profiling of breast tumors: potential for increasing black-white patient disparities in breast cancer outcomes?

Authors:  Donna H Odierna; Aimee Afable-Munsuz; Ogechi Ikediobi; Mary Beattie; Sara Knight; Michelle Ko; Adrienne Wilson; Ninez A Ponce
Journal:  Per Med       Date:  2011-11       Impact factor: 2.512

8.  Diabetes and prognosis in a breast cancer cohort.

Authors:  Michael G Schrauder; Peter A Fasching; Lothar Häberle; Michael P Lux; Claudia Rauh; Alexander Hein; Christian M Bayer; Katharina Heusinger; Arndt Hartmann; Johanna D Strehl; David L Wachter; Rüdiger Schulz-Wendtland; Boris Adamietz; Matthias W Beckmann; Christian R Loehberg
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-05       Impact factor: 4.553

9.  Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.

Authors:  Marianne Ewertz; Kathryn P Gray; Meredith M Regan; Bent Ejlertsen; Karen N Price; Beat Thürlimann; Hervé Bonnefoi; John F Forbes; Robert J Paridaens; Manuela Rabaglio; Richard D Gelber; Marco Colleoni; István Láng; Ian E Smith; Alan S Coates; Aron Goldhirsch; Henning T Mouridsen
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

Review 10.  Obesity and cancer: inflammation bridges the two.

Authors:  Ryan Kolb; Fayyaz S Sutterwala; Weizhou Zhang
Journal:  Curr Opin Pharmacol       Date:  2016-07-16       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.